Skip to main content

CCTG Connection



Published:
Category: Publications
Publication: secondary analysis HDC1

HDC1 sub-study: Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on SWOG S1826

Read More

Published:
Category: Publications
Publication: two secondary analysis MA.27
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27
Chapman J-AW, Bayani J, SenGupta S, Bartlett JMS, Piper T, Quintayo MA, Virk S, Goss PE, Ingle JN, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Tozer R, D’Souza DP, Chalchal H, Spadafora S, Stearns V, Perez EA, Gelmon KA, Whelan TJ, Elliott C, Shepherd LE, Chen BE, Taylor KJ.
Read More

Published:
Category: Publications
Publication: secondary analysis LY12 (economic analysis)
The association of health care contact days with economic measures in the CCTG LY.12 trial
Given the intensive resources required to conduct economic analyses in clinical trials, a key need is identifying scalable measures of costs. Contact days—days with health care contact outside the home—may represent such a practical measure.
 
Gupta A, Thomas T, Hay AE, Crump M, Djurfeldt MS, Cheung MC, Prica A, Shepherd LE, Chen BE, Booth CM. The association of health care contact days with economic measures in the CCTG LY.12 trial.
Read More



Published:
Category: Group updates
New links for CTEP Clinical Trials Resources

The current CTEP website at ctep.cancer.gov was retired on July 9, 2025, and all the site information was relocated to new URLs. 

 

Read More

Published:
Category: Group updates
CCTG trials in development update 2025 Q2

2025 Q2 Planned trials

Read More

Published:
Category: Trials
Trial closure: MA33

The MA33 (TROG 0701): A Randomised Phase III Study Of Radiation Doses And Fractionation Schedules For Ductal Carcinoma In Situ (DCIS) Of The Breast, has permanently closed.

Read More

Published:
Category: Trials
The BR38 trial testing targeted radiotherapy added to immunotherapy to improve outcomes for lung cancer patients.

The recently opened BR38 clinical trial is exploring whether adding stereotactic body radiotherapy (SBRT) to the current treatment of immunotherapy (with or without chemotherapy) can improve outcomes for patients with metastatic non-small cell lung cancer (NSCLC) and limited disease progression (oligoprogression).

Read More

Published:
Category: Trials
Closed to Accrual: IND.243 Cohort F

Please be aware that Cohort F on IND.243:  A Phase II Study of RP-6306 in Patients with Advanced Cancer has closed to accrual.  As Cohort F was the last opened cohort, the IND.243 main study will also be closed.  Please see the closure notice for additional details.

Read More